Related Experiment Video
Updated: May 13, 2026

Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents
Published on: October 26, 2016
Endovascular treatment of aortic coarctation using covered balloon-expandable stents-a systematic review and
Fei He1, Zhongze Cao2, Chen Wang1
1Department of Vascular Surgery, Huaihe Hospital, Henan University, Kaifong, Henan, China.
Insights
Covered balloon-expandable stents (CBSs) are safe and effective for treating coarctation of the aorta (CoA). This meta-analysis shows high success rates, significant hemodynamic improvements, and an acceptable complication profile for CBSs in CoA patients.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Device Technology
Background:
- Coarctation of the aorta (CoA) is a congenital heart defect requiring effective treatment.
- Balloon dilation and stenting are established treatments for CoA.
- Evidence on the safety and efficacy of covered balloon-expandable stents (CBSs) in a large cohort is limited.
Purpose of the Study:
- To evaluate the safety and efficacy of CBSs in treating coarctation of the aorta.
- To assess procedural success rates, hemodynamic and anatomical benefits, complications, and mid-term outcomes of CBSs for CoA.
- To provide a comprehensive meta-analysis of existing literature on CBSs for CoA.
Main Methods:
- Systematic literature search of PubMed, Embase, and Cochrane Library databases.
- Meta-analysis of 12 studies including 411 patients treated with CBSs for CoA.
- Calculation of pooled procedural success rates, complication incidences, and changes in pressure gradients and blood pressure.
Main Results:
- 100% procedural success rate for CBS implantation in CoA.
- Significant reductions in trans-coarctation pressure gradients and systolic blood pressure observed.
- Low pooled incidences of stent-related (2%), aortic (2%), and access site (3%) complications.
Conclusions:
- Covered balloon-expandable stent implantation is a safe and effective treatment for coarctation of the aorta.
- High procedural success rates and favorable hemodynamic outcomes are demonstrated.
- An acceptable incidence of complications and low re-coarctation rates support the use of CBSs for CoA.
Objectives:
Balloon dilation followed by balloon-expandable stent implantation is an effective treatment for improving hemodynamic status in patients with coarctation of the aorta (CoA). However, limited evidence exists regarding the safety and efficacy of covered balloon-expandable stents (CBSs) in a large cohort. In this meta-analysis, we aimed to evaluate the overall success rates, hemodynamic and anatomical benefits, complications, and mid-term results of CBSs in treating CoA.
Methods:
The PubMed, Embase, and Cochrane Library databases were systemically searched for studies reporting outcomes of CBSs in treating CoA. Single-group rate meta-analyses were performed to calculate estimated pooled procedural success rates, the incidence of complications, and re-coarctation rates. A meta-analysis using standardized mean differences was conducted to compare pre- and postoperative trans-coarctation pressure gradients (PGs), coarctation diameter, and overall changes in systolic blood pressure (SBP). Subgroup analyses were performed to identify potential sources of heterogeneity.
Results:
The final analysis included 12 studies with a total of 411 patients. The estimated pooled procedural success rate was 100% [95% confidence interval (CI): 98%-100%, I2 = 0, P = 0.78]. Significant decreases in trans-coarctation PGs and SBP were observed. The pooled incidences of stent-related, aortic, and access site complications were 2% (95% CI: 0%-5%, I 2 = 30.4%, P = 0.15), 2% (95% CI: 0%-4%, I 2 = 0%, P = 0.76), and 3% (95% CI: 1%-7%, I 2 = 52.9%, P = 0.02), respectively. Subgroup analyses showed that implantation of BeGraft stents was related to a significantly higher incidence of access site complications.
Conclusion:
Covered balloon-expandable stent implantation in treating CoA is safe and effective with high procedural success rates, an acceptable incidence of complications, and a low incidence of re-coarctation.
Systematic Review Registration:
https://www.crd.york.ac.uk/PROSPERO/, PROSPERO (CRD42023430356).
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aneurysm III: Interprofessional Care

